Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 10/30 11:24:41 am
21000 ILa   +2.44%
1d agoDJTeva Earnings Jump 23% On Rising Generic Drug Profits
1d ago TEVA PHARMACEUTICAL : Reports Third Quarter 2014 Results
4d agoTEVA PHARMACEUTICAL INDUSTRIES LIMIT : quaterly earnings release
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Illumina: Teva Pharmaceutical Exclusive Distributor of Verifi Test in Israel

07/01/2013 | 08:27am US/Eastern
   By Melodie Warner 
 

Illumina Inc. (>> Illumina, Inc.) said Teva Pharmaceutical Industries Ltd. (>> Teva Pharmaceutical Industries Ltd (ADR)) will be the exclusive distributor of the verifi prenatal test in Israel under a five-year agreement.

Financial terms weren't disclosed.

Illumina paid $350 million in February to buy Verinata Health Inc., which gave it access to Verinata's verifi prenatal test, the broadest non-invasive prenatal test currently available for high-risk pregnancies.

The company said the MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi test to customers of Clalit Health Services who are at high risk of having a fetus with a chromosomal abnormality.

The MOR Institute will also establish a 9,000-patient clinical outcomes registry to collect performance data and will share the data with Verinata.

Illumina said the patient registry developed through this collaboration will be the largest and most extensive of its kind.

Illumina shares closed Friday at $74.84 and were inactive premarket. The stock is up 35% this year.

Write to Melodie Warner at melodie.warner@dowjones.com

Stocks mentioned in the article : Illumina, Inc., Teva Pharmaceutical Industries Ltd (ADR)
Latest news on TEVA PHARMACEUTICAL INDUST
1d agoDJTeva Earnings Jump 23% On Rising Generic Drug Profits
1d ago TEVA PHARMACEUTICAL : Reports Third Quarter 2014 Results
2d ago TEVA PHARMACEUTICAL : Patent Issued for Wet Formulations of Aripiprazole
2d ago TEVA PHARMACEUTICALS : USA's Trademark Application for "PROAIR RESPICLICK" Filed
2d ago TEVA PHARMACEUTICALS : USA's Trademark Application for "COPAXONE" Filed
2d ago TEVA PHARMACEUTICAL : An Application for the Trademark "BIRTH CONTROL THAT FITS ..
2d ago TEVA PHARMACEUTICAL : Trademark Application for "GALZIN (ZINC ACETATE)" Filed by..
4d agoTEVA PHARMACEUTICAL INDUSTRIES LIMIT : quaterly earnings release
10/23 ALEXZA PHARMACEUTICALS : Issues Adasuve U.S. Commercial Progress
10/22 TEVA PHARMACEUTICALS : USA's Trademark Application for "CIMA ADT" Filed
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF